Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Opinion in Pharmacology|May 24, 2005
Myasthenia gravis: emerging new therapy optionsJoern P SiebSeminars in Pediatric Neurology|July 26, 2002
Congenital myasthenic syndromesJoern P Sieb, Simone Kraner, Ortrud K SteinleinNeuromuscular Disorders : NMD|March 24, 2004
Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridineBrenda L Banwell, Kinji Ohno, Joern P Sieb, et al.Archives of Neurology|May 21, 2003
Congenital myasthenic syndrome with episodic apnea in patients homozygous for a CHAT missense mutationSimone Kraner, Iris Laufenberg, Hans M Strassburg, et al.Neurology and Therapy|November 4, 2015
The European LEMS Registry: Baseline Demographics and Treatment ApproachesRenato Mantegazza, Andreas Meisel, Joern P Sieb, et al.Anesthesia and Analgesia|September 28, 2002
The effect of propofol on increased superoxide concentration in cultured rat cerebrocortical neurons after stimulation of N-methyl-d-aspartate receptorsChristian Grasshoff, Thomas GillessenToxicology Letters|March 15, 2005
Ketamine reduces cholinergic modulated GABA release from rat striatal slicesChristian Grasshoff, Thomas Gillessen, Erwin Wagner, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 10, 2007
Glutamate-induced cell death in neuronal HT22 cells is attenuated by extracts from St. John's wort (Hypericum perforatum L.)Anja Breyer, Matthias Elstner, Thomas Gillessen, et al.Toxicology|December 25, 2002
The effect of acetylcholinesterase-inhibition on depolarization-induced GABA release from rat striatal slicesChristian Grasshoff, Thomas Gillessen, Horst Thiermann, et al.Pageof 1